13-19173891-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006001.3(TUBA3C):āc.1325C>Gā(p.Ala442Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,614,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006001.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBA3C | NM_006001.3 | c.1325C>G | p.Ala442Gly | missense_variant | 5/5 | ENST00000400113.8 | NP_005992.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBA3C | ENST00000400113.8 | c.1325C>G | p.Ala442Gly | missense_variant | 5/5 | 5 | NM_006001.3 | ENSP00000382982.3 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152120Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251262Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135778
GnomAD4 exome AF: 0.000161 AC: 235AN: 1461784Hom.: 0 Cov.: 31 AF XY: 0.000155 AC XY: 113AN XY: 727180
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.1325C>G (p.A442G) alteration is located in exon 5 (coding exon 5) of the TUBA3C gene. This alteration results from a C to G substitution at nucleotide position 1325, causing the alanine (A) at amino acid position 442 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at